RxSight

(NASDAQ) RXST

Current Price$5.66

Market Cap$235.13M

Since IPO (2021)-65%

5 YearN/A

1 Year-57%

1 Month-21%

RxSight Financials at a Glance

Market Cap

$235.13M

Revenue (TTM)

$127.48M

Net Income (TTM)

$46.64M

EPS (TTM)

$-1.14

P/E Ratio

-5.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$5.66

Volume

16,468

Open

$5.55

Price

$5.66

Volume

16,468

Open

$5.55

Previous Close

$5.66

Daily Range

$5.43 - $5.66

52-Week Range

$5.30 - $16.74

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$5.66

Volume

16,468

Open

$5.55

Previous Close

$5.66

Daily Range

$5.43 - $5.66

52-Week Range

$5.30 - $16.74

RXST News

RxSight (RXST) Q2 Loss Beats Estimates

Motley Fool Markets TeamAug 7, 2025

RXST: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About RxSight

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

461

CEO

Ronald M. Kurtz, MD

Website

rxsight.com

Headquarters

Aliso Viejo, CA 92656, US

RXST Financials

Key Financial Metrics (TTM)

Gross Margin

77%

Operating Margin

-43%

Net Income Margin

-37%

Return on Equity

-17%

Return on Capital

-20%

Return on Assets

-15%

Earnings Yield

-20.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$235.13M

Shares Outstanding

41.40M

Volume

16.47K

Avg. Volume

755.30K

Financials (TTM)

Gross Profit

$103.01M

Operating Income

$48.19M

EBITDA

$39.62M

Operating Cash Flow

$15.51M

Capital Expenditure

$3.83M

Free Cash Flow

$19.34M

Cash & ST Invst.

$228.13M

Total Debt

$11.04M

RxSight Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$30.89M

-18.5%

Gross Profit

$23.50M

-17.1%

Gross Margin

76.06%

N/A

Market Cap

$235.13M

N/A

Market Cap/Employee

$472.15K

N/A

Employees

498

N/A

Net Income

$15.88M

-93.9%

EBITDA

$17.83M

-141.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$207.05M

-4.7%

Accounts Receivable

$22.44M

-27.5%

Inventory

$34.87M

+47.9%

Long Term Debt

$9.32M

-15.2%

Short Term Debt

$1.50M

+42.6%

Return on Assets

-15.34%

N/A

Return on Invested Capital

-20.01%

N/A

Free Cash Flow

$11.65M

-23.8%

Operating Cash Flow

$10.89M

-23.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TMCITreace Medical Concepts, Inc.

TMCITreace Medical Concepts, Inc.$2.66-3.97%

SMLRSemler Scientific, Inc.

SMLRSemler Scientific, Inc.$20.33-4.87%

DMACDiaMedica Therapeutics Inc.

DMACDiaMedica Therapeutics Inc.$6.06-4.72%

DCTHDelcath Systems, Inc.

DCTHDelcath Systems, Inc.$11.07-3.40%

KIDSOrthoPediatrics Corp.

KIDSOrthoPediatrics Corp.$17.72-1.01%

CERSCerus Corporation

CERSCerus Corporation$2.34-6.77%

TCMDTactile Systems Technology, Inc.

TCMDTactile Systems Technology, Inc.$22.74-1.30%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

NOKNokia

NOKNokia$13.95-0.04%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

PIIIP3 Health Partners

PIIIP3 Health Partners$11.29+1.80%

Questions About RXST

What is the current price of RxSight?

RxSight is trading at $5.66 per share.

What is the 52-week range for RxSight?

Over the past 52 weeks, RxSight has traded between $5.30 and $16.74.

How much debt does RxSight have?

As of the most recent reporting period, RxSight reported total debt of $10.83M.

How much cash does RxSight have on hand?

RxSight reported $17.57M in cash and cash equivalents in its most recent financial results.

What is RxSight’s dividend yield?

RxSight does not currently have a dividend yield.

RxSight

RxSight Financials at a Glance

RXST News

RxSight (RXST) Q2 Loss Beats Estimates

RXST: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About RxSight

RXST Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

RxSight Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RXST

What is the current price of RxSight?

What is the 52-week range for RxSight?

How much debt does RxSight have?

How much cash does RxSight have on hand?

What is RxSight’s dividend yield?

Premium Investing Services